MoneyWorks4Me

Trident Lifeline - Quaterly Results

19 Oct 2024 Evaluate
The turnover is pegged at Rs. 156.61 millions for the September 2024 quarter. The mentioned figure indicates a rise of about 57.67% as against Rs. 99.33 millions during the year-ago period.Handsome Net Profit growth of 98.77% reported above the corresponding previous quarter figure of Rs. 33.91 millions to Rs. 17.06 millions.The company reported a good operating profit of 49.40 millions compared to 25.71 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 156.61 99.33 57.67 303.98 185.76 63.64 446.52 316.92 40.89
Other Income 5.17 3.79 36.41 9.90 7.08 39.83 22.03 11.54 90.90
PBIDT 49.40 25.71 92.14 94.91 46.63 103.54 110.33 74.04 49.01
Interest 2.67 1.05 154.29 4.69 2.04 129.90 4.63 4.66 -0.64
PBDT 46.73 24.66 89.50 90.22 44.59 102.33 105.70 69.38 52.35
Depreciation 1.57 1.61 -2.48 4.83 2.94 64.29 7.70 3.65 110.96
PBT 45.16 23.05 95.92 85.39 41.65 105.02 98.00 65.73 49.09
TAX 11.25 5.99 87.81 21.35 10.57 101.99 27.56 5.61 391.27
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 3.71 5.19 -28.52
PAT 33.91 17.06 98.77 64.04 31.08 106.05 70.44 60.12 17.17
Equity 114.99 80.00 43.74 114.99 114.99 0.00 114.99 114.99 0.00
PBIDTM(%) 31.54 25.88 21.87 31.22 25.10 24.38 24.71 23.36 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..